| Статус: | Unknown status |
| Фаза: | Phase 1 |
| Начало: | 26 мая 2019 г. |
| Окончание: | 1 декабря 2020 г. |
| Описание: | This is a non-randomized multicenter phase 1b clinical trial of the safety and pharmacokinetics, as well as the preliminary efficacy of monotherapy with alofanib, an allosteric fibroblast growth factor receptor 2 inhibitor, in patients with advanced gastric cancer who have exhausted the resource of standard therapy. |
| смотреть на ClinicalTrials.gov |